News
Andreas Kalcker’s appearance at the conference highlights how dangerous alternative health claims have been growing during Trump’s second term in office.
Psychedelic drugs, like the psilocybin found in the mushrooms, disrupt neural activity in the brain and cause cognitive and ...
The U.S. Food and Drug Administration (FDA) is still negotiating whether to grant full approval to Novavax's COVID-19 vaccine ...
The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...
Those of us who paid attention to their COVID wishcasting are not the least bit surprised that measles is killing and ...
Novavax faces a setback as the FDA requests an additional trial for COVID-19 vaccine approval. Read more here.
Shares of biotech companies involved in the development of monoclonal antibody cancer therapies were moving all over the ...
Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after previously ...
(Reuters) -Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after ...
Novavax shares declined after a Wall Street Journal report that federal regulators are asking the company to complete an additional randomized clinical trial on its Covid-19 vaccine, according to ...
Federal regulators have asked Novavax (NVAX) to conduct another randomized clinical trial of its Covid-19 vaccine following earlier delays in ...
EDT Novavax (NVAX) asked by FDA to complete additional COVID trial, WSJ saysStay Ahead of the Market: Discover outperforming stocks and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results